Gara Jalqabaatti › Kansa Endometiriyaalii › Texas › Fort Worth
Qorannoo klinikaalii Kansa Endometiriyaalii Fort Worth, TX keessatti
Qorannoo 12 Kansa Endometiriyaalii f Fort Worth fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of PHST001 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- START Center for Cancer Research - Texas, Fort Worth
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- START Center for Clinical Research, Fort Worth
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Namoota walitti qabaa jiraSadarkaa 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- START Dallas Fort Worth, Fort Worth
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Namoota walitti qabaa jiraSadarkaa 3
- Texas Oncology - DFW ( Site 8004), Fort Worth
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Start - Dfw, Fort Worth
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Namoota walitti qabaa jiraSadarkaa 3
- USOR - Texas Oncology - Dallas Fort Worth (DFW), Fort Worth
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Fort Worth
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Namoota walitti qabaa jiraSadarkaa 1/2
- USOR Texas Oncology, Fort Worth
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UT Southwestern - Simmons Cancer Center - Fort Worth, Fort Worth
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Namoota walitti qabaa jiraSadarkaa 1
- START Dallas Fort Worth, LLC, Fort Worth
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Texas Oncology-Fort Worth Cancer Center, Fort Worth
Qorannoo Kansa Endometiriyaalii magaalota biroo keessatti
- Houston, TXQorannoo 68
- New York City, NYQorannoo 52
- Boston, MAQorannoo 50
- Arlington, VAQorannoo 39
- Nashville, TNQorannoo 38
- Los Angeles, CAQorannoo 34
- St. Louis, MOQorannoo 29
- Philadelphia, PAQorannoo 28
- San Antonio, TXQorannoo 27
- Columbus, OHQorannoo 25
- Oklahoma City, OKQorannoo 25
- Chicago, ILQorannoo 25
Qorannoo biroo Fort Worth keessatti
- Kansara Qara'a Non-Small CellQorannoo 18
- Kansarii OvariiQorannoo 17
- Saree OljooQorannoo 12
- Saree (Gosoota Hunda)Qorannoo 9
- Kansarii ProstateQorannoo 9
- Kansaar Onnee Triple-NegativeQorannoo 7
- Degenereshinii MakulaariiQorannoo 7
- Colitis UlcerativeQorannoo 7
- Kansara Harkaa (Karsinomaa Seli Renal)Qorannoo 7
- Cufama OnneeQorannoo 7
- Kansara MetastatikiiQorannoo 7
- Kansarii ColorectalQorannoo 7
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.